This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7https://scigraph.springernature.com/pub.10.1023/a:
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1023/A:
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33342389
rdf:type
wikibase:Item
schema:description
2002年論文 tieteellinen artikkeli научни чланак 2002年论文 επιστημονικό άρθρο vitskapeleg artikkel bài báo khoa học artículo científico publicado en 2002 2002年論文 vetenskaplig artikel artigo científico научная статья 2002年の論文 artykuł naukowy ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel سائنسی مضمون სამეცნიერო სტატია 2002 թվականի փետրվարին հրատարակված գիտական հոդված 2002 nî lūn-bûn article scientifique (publié 2002) 2002年论文 мақолаи илмӣ vitenskapelig artikkel 2002年論文 mokslinis straipsnis naučni članak artikull shkencor bilimsel makale articol științific 2002年论文 scienca artikolo article científic tudományos cikk artículu científicu espublizáu en 2002 article scientific 2002年论文 scientific article wissenschaftlicher Artikel 2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2002年論文 บทความทางวิทยาศาสตร์ artigo científico (publicado na 2002) מאמר מדעי 2002年论文 научни чланак teaduslik artikkel artikulong pang-agham مقالهٔ علمی 2002年論文 artigo científico (publicado na 2002) наукова стаття, опублікована в лютому 2002 articolo scientifico научна статия vedecký článok мақолаи илмӣ 2002년 논문 vědecký článek videnskabelig artikel (udgivet 2002) 2002年论文 مقالة علمية
p:P577
wds:Q33342389-EFC5CE36-7015-4411-B541-85871F6260B7
wdt:P577
2002-02-01T00:00:00Z
p:P2888
wds:Q33342389-B1EC5C3D-5FB2-4CA2-8B9C-577A16561B6D
wdt:P2888
n7:1014473930546
p:P2860
wds:Q33342389-FB6C7302-A0FF-428F-A6DC-65DA4BBAB375 wds:Q33342389-EC0686EA-D60A-4DD5-8A85-AFED9C4EEC96 wds:Q33342389-02EF6F15-B96A-4B4E-A8B2-26EF738BBCE2 wds:Q33342389-249ED0D2-6154-4F82-9B89-1347B4C14483 wds:Q33342389-6EF153E8-50B1-45C3-BE9B-A3E057E2BC78 wds:Q33342389-38BD94EA-C110-4956-A083-41975D01671B wds:Q33342389-3A9B02F2-B5B7-448A-AF86-6E88214EEB48 wds:Q33342389-7CD7972E-CDBF-4097-8753-E707EB8626EA wds:Q33342389-925840C9-3165-4ED9-9BAF-8842E8D8D99A
wdt:P2860
wd:Q33656837 wd:Q40673230 wd:Q33330768 wd:Q33503343 wd:Q77128634 wd:Q33499775 wd:Q74545971 wd:Q74756518 wd:Q33488295
p:P2093
wds:Q33342389-A7987F7C-5DEA-406C-9A39-3E87787CD061 wds:Q33342389-A38D9915-8D46-4F81-BD6E-9A5735134192 wds:Q33342389-B5A03F22-77AD-4AB2-A585-26FBFFF70C3B wds:Q33342389-C2D00911-76B1-463E-BCBC-18AC9D82BD61 wds:Q33342389-E9335334-F659-422C-884C-3AD2D639EA42 wds:Q33342389-5C126B52-0744-4A04-8ACE-59F4B5B434BE wds:Q33342389-79A7F325-9FCA-43A9-BDDC-CB7B7ED00077 wds:Q33342389-9579B127-0AD0-4824-BD33-49D3222F6817 wds:Q33342389-9AFA9F16-1AD6-4F31-982C-7839869B7365
wdt:P2093
Dana Thompson Valerie Johnson Howard A Burris David Lebwohl F Anthony Greco Sharon Calvert Eric Raefsky Cecile Bulanhagui Suzanne Jones
rdfs:label
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies
skos:prefLabel
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies
schema:name
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies
p:P50
wds:Q33342389-93DF65F0-8404-4FC9-939F-BC34732435A6
wdt:P50
wd:Q73567269
p:P1476
wds:Q33342389-9C5B9987-24B1-408E-8F86-43E7B1360A69
wdt:P1476
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies
p:P304
wds:Q33342389-C6B74A44-93CF-4ED3-9D55-6A6DE7C9F432
wdt:P304
55-61
p:P31
wds:Q33342389-CCE41B5D-54C2-4FED-9461-101FD9F67F31
wdt:P31
wd:Q13442814
p:P921
wds:Q33342389-3B1F015F-4D6F-4025-A040-61F61FDAF13F wds:Q33342389-49AB8AFC-EE5A-40CC-BBE1-C1B0B973A7B3
wdt:P921
wd:Q423762 wd:Q2226212
p:P698
wds:Q33342389-949F818C-F2FB-4D4C-BE90-BF398ABBA309
wdtn:P698
n13:12008664
wdt:P698
12008664
p:P1433
wds:Q33342389-3C984DA5-560D-49E1-B45D-FD92E7FE9B2A
wdt:P1433
wd:Q2312231
p:P433
wds:Q33342389-5EAFD876-5C19-4F81-ACFE-E7AFD94C8B8A
p:P478
wds:Q33342389-C30CC46C-647E-46C7-B99F-C95346DA16F6
wdt:P433
1
wdt:P478
20
p:P356
wds:Q33342389-70E0EAB7-6329-47E0-BA1A-6C8110804106
wdtn:P356
n11:1014473930546
wdt:P356
10.1023/A:1014473930546
p:P6179
wds:Q33342389-C5297F49-B15E-4A70-97F2-B5333944C12A
wdt:P6179
1017045470